Abbvie Inc
NYSE: ABBV
$181.14
+$4.08 (+2.3%)
Closing Price on November 26, 2024
ABBV Articles
With the potential for a sizable market correction looming, it might be a good idea for investors to look at stocks on the Dividend Aristocrats list that are in sectors poised to do well for the rest...
Published:
America's two largest energy companies report March quarter results Friday morning, along with two big pharmaceutical makers.
Published:
Wednesday's top analyst upgrades and downgrades included AbbVie, Alcoa, Anheuser Busch, Applied Materials, CyberArk, Fox, Merck, Paychex, ViacomCBS and Waste Management.
Published:
With the stock market very overbought and interest rates still very close to generational lows, top-quality dividend stocks may be the way to go for the rest of 2021. Here are five that could offer...
Published:
Rome was not built in a day, and neither are multibillion-dollar corporations. Biopharmaceuticals company AbbVie is the largest American company founded in the past decade.
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
Wednesday's top analyst upgrades and downgrades included AbbVie, Albertsons, DuPont, Exxon Mobil, Home Depot, KB Home, Mastercard, Palantir and Twitter.
Published:
With even moderate appreciation in the shares prices of these top companies, investors could be looking at double-digit total return potential. In a market that is very long in the tooth, that makes...
Published:
Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may be one of the best ideas for 2021.
Published:
Wednesday's top analyst upgrades and downgrades included Baidu, BigCommerce, Boeing, Ciena, Deere, GoodRx, Kohl's, ONEOK, Tesla and Walmart.
Published:
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
Published:
Last Updated:
Here are six health care stocks that appear to be specific winners based on a mixed Congress, regardless of which presidential candidate is declared the winner.
Published:
Monday's top analyst upgrades and downgrades included AbbVie, Alibaba, Archer Daniels Midland, Best Buy, Intel, Nikola, Peloton Interactive, SAP, Under Armour and Wynn Resorts.
Published:
Last Updated:
Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These five dividend-paying health care stocks are all favored by large-cap portfolio managers.
Published: